November 30, 2016
(Washington, D.C.) — A new national survey finds most voters blame drug companies not only for high drug prices, but also for out-of-pocket costs. The findings undermine the drug industry’s $100 million PR campaign to blame higher costs on employers, unions, health plans and the pharmacy benefit managers (PBMs) they use to negotiate discounts on prescription drugs.
“Consumers are well aware drug companies set drug prices and they know higher prices mean higher out-of-pocket costs. No one’s buying the drug companies’ campaign to shift blame to employers, unions, plans, or the PBMs that negotiate discounts on their behalf,” said Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt.
North Star Opinion Research surveyed 1,000 registered voters nationwide.
Key findings from survey include:
• By almost 3-to-1, voters blame high drug prices for increased cost-sharing.
• Only 1-in-5 voters buy the drugmakers’ “rebates cause high prices” message.
• Three-quarters of voters say the cost of prescription drugs is too high.
• More than 4-of-5 voters with prescription drug coverage are satisfied with it.